Ohki Health Care Holdings, Inc. AI Stock Analysis
Want to see JP:3417 full AI Analyst Report?
Ohki Health Care Holdings, Inc. (3417) AI Stock Analysis
Ohki Health Care Holdings, Inc.
(TSE/TYO:3417)
The overall score is very low, driven primarily by poor financial performance and a bearish technical trend. The company's core operations generate thin, volatile profits and unpredictable negative cash flows, which is a significant risk. The stock is in a clear downtrend, trading below all major moving averages. A moderate valuation and decent dividend yield provide only a minor cushion against these fundamental and technical headwinds.
Ohki Health Care Holdings, Inc. (3417) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 13.45B
- Dividend Yield
- 3.02%
- Average Volume (3M)
- 10.69K
- Price to Earnings (P/E)
- 18.1
- Beta (1Y)
- 0.30
- Revenue Growth
- 2.87%
- EPS Growth
- -73.55%
- Country
- Japan
- Employees
- 685
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Ohki Health Care Holdings, Inc. Business Overview & Revenue Model
Company Description
Ohki Healthcare Holdings Co.,Ltd., a venerable Japanese enterprise founded in Tokyo in 1658, operates with a broad and diversified portfolio across numerous sectors. The company primarily engages in the import, export, distribution, and sale of an ex...
How the Company Makes Money
Ohki Health Care Holdings primarily makes money through wholesale distribution within Japan’s healthcare supply chain. The company purchases pharmaceuticals and other healthcare-related products from manufacturers and marketing authorization holders,...
Ohki Health Care Holdings, Inc. Financial Statement Overview
Summary
Financial performance is weak. The Income Statement (Score 35) shows thin, declining margins and volatile net income. The Cash Flow Statement (Score 25) indicates highly unpredictable and negative operating cash flows, raising liquidity concerns. These are partially offset by a solid Balance Sheet (Score 55) with manageable debt, but overall financial health is poor due to operational instability.
Income Statement
35NegativeBalance Sheet
55NeutralCash Flow
25Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 363.02B | 360.36B | 349.45B | 334.66B | 304.44B | 278.16B |
| Gross Profit | 17.15B | 17.24B | 18.19B | 16.89B | 15.58B | 13.42B |
| EBITDA | 391.00M | 1.17B | 3.16B | 2.42B | 2.44B | 981.00M |
| Net Income | 750.00M | 1.34B | 2.64B | 2.21B | 2.18B | 971.00M |
Balance Sheet | ||||||
| Total Assets | 154.17B | 148.39B | 140.96B | 140.08B | 123.96B | 115.39B |
| Cash, Cash Equivalents and Short-Term Investments | 3.65B | 2.21B | 2.88B | 8.31B | 3.24B | 2.77B |
| Total Debt | 20.95B | 15.62B | 14.21B | 6.95B | 8.48B | 7.50B |
| Total Liabilities | 120.83B | 114.22B | 109.90B | 112.18B | 99.68B | 93.29B |
| Stockholders Equity | 33.34B | 34.16B | 30.99B | 27.84B | 24.13B | 21.95B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -2.74B | -12.03B | 7.27B | -138.00M | 1.22B |
| Operating Cash Flow | 0 | -1.42B | -9.18B | 7.55B | 96.00M | 1.31B |
| Investing Cash Flow | 0 | -671.00M | -3.13B | -496.00M | -291.00M | 68.00M |
| Financing Cash Flow | 0 | 1.42B | 6.89B | -2.00B | 681.00M | -1.40B |
Ohki Health Care Holdings, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3417, the sentiment is Positive. The current price of 995.00 is above the 20-day moving average (MA) of 975.60, above the 50-day MA of 994.50, and below the 200-day MA of 1170.23, indicating a neutral trend. The MACD of -1.58 indicates Negative momentum. The RSI at 54.58 is Neutral, neither overbought nor oversold. The STOCH value of 45.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3417.
Ohki Health Care Holdings, Inc. Peers Comparison
Overall Rating
JP:339181Outperform
JP:314870Outperform
JP:764969Neutral
JP:334959.9Neutral
JP:354959Neutral
JP:341742Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 81Outperform | JPY 1.12T | 19.58 | 7.13% | 1.88% | ― | ― | |
| 70Outperform | JPY 207.36B | 12.66 | ― | 2.83% | 8.67% | 3.24% | |
| 69Neutral | JPY 532.23B | 17.51 | 9.94% | 1.24% | 8.97% | -29.54% | |
| 60Neutral | JPY 505.70B | 15.88 | ― | 1.27% | 8.99% | 3.61% | |
| 59Neutral | JPY 482.38B | 25.45 | ― | 0.29% | 12.54% | 15.87% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 42Neutral | JPY 13.96B | 18.12 | ― | 3.02% | 2.87% | -73.55% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3417 | Ohki Health Care Holdings, Inc. | 995.00 | -402.29 | -28.79% | |
| JP:7649 | Sugi Holdings Co | 1416.50 | -292.70 | -17.12% | |
| JP:3391 | TSURUHA Holdings | 2500.00 | -202.22 | -7.48% | |
| JP:3148 | Create SD Holdings Co., Ltd. | 3290.00 | 167.31 | 5.36% | |
| JP:3349 | COSMOS Pharmaceutical Corporation | 6437.00 | -929.03 | -12.61% | |
| JP:3549 | KUSURI NO AOKI HOLDINGS CO.,LTD. | 5073.00 | 1236.35 | 32.22% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 19, 2026
